Go to Previous Versions
of
this Section
2024 U.S. Code
Title 21 - Food and Drugs
Chapter 9 - Federal Food, Drug, and Cosmetic Act
Subchapter V - Drugs and Devices
Part B - Drugs for Rare Diseases or Conditions
Sec. 360dd - Open protocols for investigations of drugs for rare diseases or conditions
Download PDF
| 21 U.S.C. § 360dd (2024) |
| §360dd. Open protocols for investigations of drugs for rare diseases or conditions |
|
If a drug is designated under section 360bb of this title as a drug for a rare disease or condition and if notice of a claimed exemption under section 355(i) of this title or regulations issued thereunder is filed for such drug, the Secretary shall encourage the sponsor of such drug to design protocols for clinical investigations of the drug which may be conducted under the exemption to permit the addition to the investigations of persons with the disease or condition who need the drug to treat the disease or condition and who cannot be satisfactorily treated by available alternative drugs. |
|
(June 25, 1938, ch. 675, §528, as added Pub. L. 97–414, §2(a), Jan. 4, 1983, 96 Stat. 2051.) |
| United States Code, 2024 Edition, Title 21 - FOOD AND DRUGS |
| Bills and Statutes |
| United States Code |
| Y 1.2/5: |
| Title 21 - FOOD AND DRUGS CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT SUBCHAPTER V - DRUGS AND DEVICES Part B - Drugs for Rare Diseases or Conditions Sec. 360dd - Open protocols for investigations of drugs for rare diseases or conditions |
| section 360dd |
| 2024 |
| January 6, 2025 |
| No |
| standard |
| 96 Stat. 2051 |
| Public Law 97-414 |
Disclaimer: These codes may not be the most recent version. United States may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
